MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimada, S.
Right arrow Articles by Uhl, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimada, S.
Right arrow Articles by Uhl, G. R.

gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine- insensitive gamma-aminobutyric acid responses in Xenopus oocytes

S Shimada, G Cutting and GR Uhl

Laboratory of Molecular Neurobiology, ARC/NIDA, Baltimore, Maryland.

Xenopus oocyte expression of the recently cloned gamma-aminobutyric acid (GABA) rho 1 receptor subunit cDNA yields a pharmacologic profile characteristic of the GABAc responses described by Johnston [Benzodiazepine/GABA Receptors and Chloride Channels. Receptor Biochemistry and Methodology (R. W. Olsen and J. C. Venter, eds), Vol. 5. Alan R. Liss, New York, 57-71 (1986)] and the responses to retinal mRNA recently reported in the Xenopus expression system [Proc. Natl. Acad. Sci. USA 88:4318-4322 (1991)]. A rationale for defining GABA rho 1 as forming a GABAc receptor is discussed.

Volume 41, Issue 4, pp. 683-687, 04/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
J. J. Yi and M. D. Ehlers
Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function
Pharmacol. Rev., March 1, 2007; 59(1): 14 - 39.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
V. C. Cuzon, P. W. Yeh, Q. Cheng, and H. H. Yeh
Ambient GABA Promotes Cortical Entry of Tangentially Migrating Cells Derived from the Medial Ganglionic Eminence
Cereb Cortex, October 1, 2006; 16(10): 1377 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
J. Yang, Q. Cheng, A. Takahashi, and F. Goubaeva
Kinetic Properties of GABA {rho}1 Homomeric Receptors Expressed in HEK293 Cells
Biophys. J., September 15, 2006; 91(6): 2155 - 2162.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. J. Milligan, N. J. Buckley, M. Garret, J. Deuchars, and S. A. Deuchars
Evidence for Inhibition Mediated by Coassembly of GABAA and GABAC Receptor Subunits in Native Central Neurons
J. Neurosci., August 18, 2004; 24(33): 7241 - 7250.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. D. W. Morris and J. Amin
Insight into the Mechanism of Action of Neuroactive Steroids
Mol. Pharmacol., July 1, 2004; 66(1): 56 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Dean, S. J. Robertson, and F. A. Edwards
Serotonin Drives a Novel GABAergic Synaptic Current Recorded in Rat Cerebellar Purkinje Cells: A Lugaro Cell to Purkinje Cell Synapse
J. Neurosci., June 1, 2003; 23(11): 4457 - 4469.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. I. Torres and D. S. Weiss
Identification of a Tyrosine in the Agonist Binding Site of the Homomeric rho 1 gamma -Aminobutyric Acid (GABA) Receptor That, When Mutated, Produces Spontaneous Opening
J. Biol. Chem., November 8, 2002; 277(46): 43741 - 43748.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
G. M. Ekema, W. Zheng, and L. Lu
Interaction of GABA Receptor/Channel {rho}1 and {gamma}2 Subunit
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2326 - 2333.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. A. McCall, P. D. Lukasiewicz, R. G. Gregg, and N. S. Peachey
Elimination of the rho 1 Subunit Abolishes GABAC Receptor Expression and Alters Visual Processing in the Mouse Retina
J. Neurosci., May 15, 2002; 22(10): 4163 - 4174.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Engblom, B. X. Carlson, R. W. Olsen, A. Schousboe, and U. Kristiansen
Point Mutation in the First Transmembrane Region of the beta 2 Subunit of the gamma -Aminobutyric Acid Type A Receptor Alters Desensitization Kinetics of gamma -Aminobutyric Acid- and Anesthetic-induced Channel Gating
J. Biol. Chem., May 10, 2002; 277(20): 17438 - 17447.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. J. Jentsch, V. Stein, F. Weinreich, and A. A. Zdebik
Molecular Structure and Physiological Function of Chloride Channels
Physiol Rev, April 1, 2002; 82(2): 503 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Cheng, J. C. Kulli, and J. Yang
Suppression of Neuronal Hyperexcitability and Associated Delayed Neuronal Death by Adenoviral Expression of GABAC Receptors
J. Neurosci., May 15, 2001; 21(10): 3419 - 3428.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Billups, J. G. Hanley, M. Orme, D. Attwell, and S. J. Moss
GABAC Receptor Sensitivity Is Modulated by Interaction with MAP1B
J. Neurosci., December 1, 2000; 20(23): 8643 - 8650.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Pattnaik, A. Jellali, J. Sahel, H. Dreyfus, and S. Picaud
GABAC Receptors Are Localized with Microtubule-Associated Protein 1B in Mammalian Cone Photoreceptors
J. Neurosci., September 15, 2000; 20(18): 6789 - 6796.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Boue-Grabot, A. Taupignon, G. Tramu, and M. Garret
Molecular and Electrophysiological Evidence for a GABAC Receptor in Thyrotropin-Secreting Cells
Endocrinology, May 1, 2000; 141(5): 1627 - 1632.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Hanley, E. M. C. Jones, and S. J. Moss
GABA Receptor rho 1 Subunit Interacts with a Novel Splice Variant of the Glycine Transporter, GLYT-1
J. Biol. Chem., January 14, 2000; 275(2): 840 - 846.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. J. Delaney and P. Sah
GABA Receptors Inhibited by Benzodiazepines Mediate Fast Inhibitory Transmission in the Central Amygdala
J. Neurosci., November 15, 1999; 19(22): 9698 - 9704.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Pasternack, M. Boller, B. Pau, and M. Schmidt
GABAA and GABAC Receptors Have Contrasting Effects on Excitability in Superior Colliculus
J Neurophysiol, October 1, 1999; 82(4): 2020 - 2023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Perret, X. Sarda, M. Wolff, T.-T. Wu, D. Bushey, and M. Goeldner
Interaction of Non-competitive Blockers within the gamma -Aminobutyric Acid Type A Chloride Channel Using Chemically Reactive Probes as Chemical Sensors for Cysteine Mutants
J. Biol. Chem., September 3, 1999; 274(36): 25350 - 25354.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Amin
A Single Hydrophobic Residue Confers Barbiturate Sensitivity to gamma -Aminobutyric Acid Type C Receptor
Mol. Pharmacol., March 1, 1999; 55(3): 411 - 423.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES
Pharmacology of CFTR Chloride Channel Activity
Physiol Rev, January 1, 1999; 79(1): 109 - 144.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. A. Barnard, P. Skolnick, R. W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A. N. Bateson, and S. Z. Langer
International Union of Pharmacology. XV. Subtypes of gamma -Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function
Pharmacol. Rev., June 1, 1998; 50(2): 291 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. D. Krasowski, S. E. Finn, Q. Ye, and N. L. Harrison
Trichloroethanol Modulation of Recombinant GABAA, Glycine and GABA rho 1 Receptors
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 934 - 942.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. D. Krasowski, V. V. Koltchine, C. E. Rick, Q. Ye, S. E. Finn, and N. L. Harrison
Propofol and Other Intravenous Anesthetics Have Sites of Action on the gamma -Aminobutyric Acid Type A Receptor Distinct from That for Isoflurane
Mol. Pharmacol., March 1, 1998; 53(3): 530 - 538.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. K. Machu, S. J. Mihic, and J. E. Dildy-Mayfield
Selective Actions of a Detergent on Ligand-Gated Ion Channels Expressed in Xenopus Oocytes
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 32 - 36.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z.-H. Pan, D. Zhang, X. Zhang, and S. A. Lipton
Agonist-induced closure of constitutively open gamma -aminobutyric acid channels with mutated M2 domains
PNAS, June 10, 1997; 94(12): 6490 - 6495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. S. Hackam, T.-L. Wang, W. B. Guggino, and G. R. Cutting
The N-terminal Domain of Human GABA Receptor rho 1 Subunits Contains Signals for Homooligomeric and Heterooligomeric Interaction
J. Biol. Chem., May 23, 1997; 272(21): 13750 - 13757.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. N. Yamoah and T. Crow
Protein Kinase and G-Protein Regulation of Ca2+ Currents in Hermissenda Photoreceptors by 5-HT and GABA
J. Neurosci., August 1, 1996; 16(15): 4799 - 4809.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Enz, J. H. Brandstatter, H. Wassle, and J. Bormann
Immunocytochemical Localization of the GABAC Receptor rho  Subunits in the Mammalian Retina
J. Neurosci., July 15, 1996; 16(14): 4479 - 4490.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics